Laurent O Mosnier Selected Research

Lipopolysaccharides

4/2013

Organ-specific protection against lipopolysaccharide-induced vascular leak is dependent on the endothelial protein C receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laurent O Mosnier Research Topics

Disease

22	Hemorrhage 01/2022 - 09/2004
9	Inflammation (Inflammations) 04/2024 - 01/2009
8	Sepsis (Septicemia) 01/2018 - 09/2004
7	Ischemic Stroke 01/2019 - 04/2012
6	Hemophilia A (Haemophilia) 12/2020 - 01/2002
4	Thrombosis (Thrombus) 01/2020 - 09/2006
4	Malaria 01/2019 - 01/2014
4	Stroke (Strokes) 01/2018 - 09/2006
3	Endotoxemia 04/2013 - 10/2007
2	Neoplasms (Cancer) 01/2023 - 06/2003
2	Cerebral Malaria 01/2019 - 11/2015
2	Central Nervous System Cavernous Hemangioma 01/2019 - 01/2019
2	Joint Diseases (Joint Disease) 01/2016 - 11/2015
2	Venous Thrombosis (Deep-Vein Thrombosis) 04/2012 - 04/2007
2	Purpura Fulminans 04/2012 - 04/2007
2	Activated Protein C Resistance (APC Resistance) 03/2012 - 04/2007
1	Sickle Cell Anemia (Hemoglobin S Disease) 04/2024
1	Thromboinflammation 04/2024
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Atherosclerosis 11/2022
1	Reperfusion Injury 01/2020
1	Myocardial Infarction 01/2020
1	Hemarthrosis 11/2019
1	Vascular Remodeling 10/2019
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2019
1	Ischemia 11/2016
1	Thrombotic Stroke 11/2016
1	Epidural Abscess 03/2016
1	Herpes Zoster 11/2014
1	Lacerations 01/2014
1	Infarction (Infarctions) 08/2013
1	Edema (Dropsy) 08/2013
1	Albuminuria 04/2013
1	Weight Loss (Weight Reduction) 04/2013
1	Vascular Diseases (Vascular Disease) 01/2013
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2013
1	Peritonitis 10/2007

Drug/Important Bio-Agent (IBA)

22	Protein CIBA 04/2024 - 09/2004
15	AnticoagulantsIBA 01/2023 - 09/2004
10	Endothelial Protein C ReceptorIBA 01/2023 - 10/2007
6	Proteins (Proteins, Gene)FDA Link 05/2016 - 10/2007
5	Factor VIII (Coagulation Factor VIII)IBA 11/2019 - 01/2018
4	PAR-1 ReceptorIBA 04/2024 - 03/2009
4	Thrombin FDA Link 04/2024 - 03/2009
4	Factor VaIBA 01/2022 - 01/2014
4	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 10/2019 - 01/2002
3	Tissue Plasminogen Activator (Alteplase)FDA Link 12/2018 - 11/2016
2	Peptides (Polypeptides)IBA 04/2024 - 11/2014
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 04/2024 - 12/2018
2	Peptide Hydrolases (Proteases)FDA Link 04/2024 - 11/2022
2	DisulfidesIBA 01/2022 - 11/2020
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2016
2	ThrombomodulinIBA 01/2019 - 01/2011
2	Blood Coagulation Factors (Coagulation Factor)IBA 01/2016 - 11/2015
2	Factor V (Coagulation Factor V)IBA 01/2016 - 04/2012
2	Therapeutic UsesIBA 01/2014 - 09/2004
2	BradykininIBA 01/2011 - 11/2007
1	Histocompatibility Antigens Class IIIBA 03/2024
1	Factor VII (Proconvertin)IBA 01/2023
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 11/2022
1	Apolipoproteins E (ApoE)IBA 11/2022
1	Kallikreins (Kallikrein)IBA 11/2022
1	Serine Proteases (Serine Protease)IBA 11/2022
1	Monoclonal AntibodiesIBA 12/2020
1	Factor Xa InhibitorsIBA 11/2020
1	FIIaIBA 11/2020
1	Dabigatran FDA Link 11/2020
1	RivaroxabanIBA 11/2020
1	apixabanIBA 11/2020
1	Troponin IIBA 01/2020
1	FibrinIBA 01/2020
1	PlasminogenIBA 10/2019
1	Blocking AntibodiesIBA 01/2019
1	InflammasomesIBA 01/2019
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 10/2018
1	activated protein C receptorIBA 11/2016
1	Polymethyl Methacrylate (Sol)IBA 11/2016
1	artemisinin (artemisinine)IBA 05/2016
1	A-factor (Streptomyces)IBA 03/2016
1	Factor VIIa (Activated Factor VII)IBA 03/2016
1	Plasmodium falciparum erythrocyte membrane protein 1IBA 11/2015
1	LigandsIBA 11/2014
1	Hemoglobins (Hemoglobin)IBA 08/2013
1	LipopolysaccharidesIBA 04/2013
1	Evans Blue (Blue, Evans)FDA Link 04/2013
1	HDL LipoproteinsIBA 04/2012
1	LipidsIBA 04/2012
1	Protein SIBA 04/2012
1	Neuroprotective AgentsIBA 04/2012
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 01/2011
1	Heparin (Liquaemin)FDA LinkGeneric 01/2011
1	EndotoxinsIBA 06/2009
1	CoagulantsIBA 03/2009
1	CarboxypeptidasesIBA 11/2007

Therapy/Procedure

12	Therapeutics 12/2020 - 09/2004
1	Craniotomy 03/2016
1	Surgical Instruments (Clip) 01/2014
1	Aftercare (After-Treatment) 08/2013
1	Stents 10/2007